This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With the proliferation of less accurate temperature monitoring options during the pandemic, it’s vital now more than ever that hospitals and medical facilities are leveraging accurate, trustworthy tools and technologies that promote patientsafety.
BM Birla has initiated the programme to improve its capability to provide personalised care while promoting patientsafety and outcomes and raising its standards of cardiac care delivery.
1 Despite advances over the past decade and the technology’s power to enhance patientsafety and enable greater efficiencies, Andrew Meyer, Director of Global Standards at GS1 US, said many healthcare organizations remain “gun shy” about RFID.
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patientsafety while maintaining compliance with stringent regulatory standards. The Role of Real-Time Monitoring in PatientSafety To ensure their safety, medical products must be closely watched throughout their lifecycle.
What You Should Know: – Inovalon , a provider of cloud-based healthcare data analytics solutions, announced today the acquisition of VigiLanz , a prominent provider of SaaS-based clinical surveillance and patientsafety software. billion in the lifesciences sector.
By integrating genAI into the fabric of healthcare, we stand really on the brink of a new frontier in medicine and lifesciences. While EHRs were intended to streamline documentation, improve patient coordination and enhance patientsafety, the adoption has often led to unintended consequences.
“Poor data quality undermines the ability of healthcare organizations to improve patient outcomes while controlling costs,” said Riju Khetarpal, director, Healthcare and LifeSciences ISV Partnerships at Google Cloud.
His vision for doing so builds upon the FDA’s existing partnerships with healthcare providers, lifesciences companies, patient advocates, and others. To make it easier for stakeholders to generate real-world evidence about drug efficacy, patientsafety, and clinical care, we must liberate our data.
We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way lifescience companies approach and execute pharmaceutical research. 21 st Century Patient Treatment for Rare Illnesses. Making Clinical Trials Data More Accessible for HCPs & Patients.
This loss of labor and expertise will significantly impact the pharmacovigilance (PV) space – especially as the field traditionally incorporates many manual processes to facilitate regulatory compliance and ensure patientsafety. PV teams can turn to automation to manage the impact of workforce shortages.
Ian Manners, Chief Strategy Officer & Head of LifeSciences at TailorMed. Each year, clinicians are presented with thousands of medication-related alerts in their EHR and pharmacy systems—typically disregarding more than 73% of them—contributing to burnout and potentially impacting patientsafety.
Ferdinand Hamada, Managing Director and Pharma LifeSciences Industry Lead Partner at MorganFranklin Consulting The role of the Chief Information Security Officer (CISO) has evolved far beyond traditional cybersecurity responsibilities, especially in healthcare organizations.
Patientsafety and quality of care will continue to be impacted by the quality of data available to clinicians for diagnosing and treating patients. Health systems may be forced to make hard choices like cutting or limiting services that could adversely impact patient access to care.
What You Should Know: ArisGlobal , a provider of lifesciences software acquires SPORIFY , the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.
Those “waves of demand” TripleTree described will impact every segment of care delivery and sponsor, including small to mid-sized physician practices, employers, behavioral/mental health, public/government-sponsored health care programs, and the pharma and lifescience industry.
What You Should Know: – Bluesight , a provider of medication intelligence solutions, released its 2024 Diversion Trends Report , offering valuable insights for healthcare providers to improve controlled substance monitoring and patientsafety.
To help with that balance, lifesciences organizations need to embrace operational efficiency upgrades like advanced cognitive computing to manage rising case volumes, increased signal noise, and antiquated manual tasks. PV signal teams must balance growing workloads with maintaining regulatory compliance.
Given the risks to patientsafety and clinical teams, as well as the potential reputational and financial impact on the hospital itself, hospital leadership should consider how sophisticated technology can keep these programs running smoothly.
– Medidata Detect provides end-to-end data and risk surveillance, giving cross-functional operational teams the ability to monitor and mitigate risks to patientsafety and data integrity. Medidata Detect and Rave CTMS.
Kit Check, a automation vendor in Medication Intelligence solutions that brings savings, efficiency, and patientsafety to Hospitals around the country appoints Vijay Venkatesh as Chief Technology Officer.
Deeper insights to optimize PV efficiencies PV teams can leverage their safety data to drive more efficient compliance, avoid potential risks or bottlenecks, and optimize patientsafety. About Beena Wood Beena Wood is the Senior Vice President of Product Management, Safety and Medical Affairs, at ArisGlobal.
Improving Patient Reliability and Trust in Prescription Medications Pulse can help users improve patientsafety by assisting them in identifying the threats created due to the ever-increasing complexity of the supply chain, including falsified, substandard, or counterfeit drugs and “grey market” companies.
Manual process handling leads to inefficiencies, higher error rates, and compromised patientsafety. About Sri Tella Sri Tella is the Senior Director of Technical Product Management at McKesson , and leads transformative CPQ initiatives for Healthcare and LifeSciences organizations.
By adopting a holistic perspective and proactively mitigating potential risks, health technology companies can drive innovation while safeguarding patientsafety and public trust. Disruptions, counterfeit components, and quality control issues can severely affect patientsafety and product efficacy.
What You Should Know: FluidAI Medical (FluidAI) , a pioneer in leveraging artificial intelligence (AI) for postoperative patient monitoring, today announced that it has raised $15 million in Series A funding, led by SOSV and Graphene Ventures. Juno Pharmaceuticals , and a number of esteemed angels, funds and government funding organizations.
We partner with all the top 10 pharmacy retailers, 8 of the top 10 lifescience companies, and 90% of U.S. Another very common use of our data is to leverage our vast consumer data warehouse and linking capabilities to help ensure disparate patient records are linked appropriately. For their patients?
To guarantee accurate research is conducted, clinical trials must be continually monitored to identify and remove any potential risks related to patientsafety, data accuracy, and adherence to protocol. Step 3: Optimizing Quality Assurance Through Clinical Monitoring Once a study has kicked off, multiple pressures follow.
Ensuring patientsafety and product efficacy while maintaining compliance with regulatory standards is critical, and the right technology and human knowledge of regional nuances can help ease the transition into the JAPAC region.
By testing for both genes in one overarching test, physicians can better prevent negative reactions to drugs and improve patientsafety. This pre-emptive multi-gene panel testing has already started developing in several institutions, like UCSF , which recently launched its PGx program to proactively aid patient care.
To ensure data insights are appropriately leveraged to inform decisions with patientsafety and data quality in mind, sponsors and clinical research organization partners must define the data strategy before protocol design.
Enhancing workforce well-being Deloitte’s LifeSciences & Health Care team recently wrote about Restoring purpose in health care work through technology and workforce innovation. The report calls out the link between staffing shortages, workforce burnout, and lack of trust in leadership.
It is essential to have a way to securely authenticate patients, match, and link disparate patient records, and enhance patient profiles with up-to-date and more accurate information, while mitigating cyber threats. These industry needs drive the core of The Health Care business of LexisNexis® Risk Solutions.
Providers looking to maximize reimbursement in value-based reimbursement arrangements will engage patients on socioeconomic factors that they can influence to help ensure the best possible health outcomes. These efforts will support faster care path decisions, manage claim costs and share digestible patient history with a patient’s care team.
The hearts and minds of nurses are fertile and inspirational sources and engines for health care innovation. This past weekend, and for the second time, I had the privilege and opportunity to be a panelist for the perennial hackathon meet-up of Nurse Hack 4 Health , sponsored by Microsoft, Johnson & Johnson, Sonnier, and DevUp.
A tenth indicator, patient support during the COVID-19 pandemic, was added in this year’s study. Patient-group relationships. Patientsafety. Patient information. Patient centricity, and, Integrity, plus. The key indicators of pharma reputation were, Involvement in R&D. Transparency.
Collaborating with healthcare and lifescience organizations, Atropos Health bridges evidence gaps from research to patient care, enhancing individual outcomes through data-driven care and accelerating advancements in medicine. Institutions can also partner with advanced models developed by others.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content